Otto Energy Limited ("Otto") (ASX:OEL), as operator of the producing Galoc oilfield joint venture offshore the Philippines, provides the following update on Galoc operations in SC14C. Ongoing operations Super Typhoon Haiyan passed ...
Switzerland-based Helsinn group has granted Chugai Pharma Marketing, a wholly-owned subsidiary of Chugai Pharmaceutical, exclusive commercialization rights to their ghrelin receptor agonist, anamorelin, for the three major European pharma ...
Tags: Helsinn group, Pharma Marketing
Discovery Laboratories, a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, has announced that the US Food and Drug Administration (FDA) has cleared the company's investigational new drug ...
Tags: Discovery Labs, Medicine
Canadian biopharmaceutical firm Aeterna Zentaris has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for its ghrelin agonist, macimorelin acetate (AEZS-130), a novel orally-active small molecule. The ...
Tags: Aeterna Zentaris, Medicine
Documents filed on Surya's behalf indicate that the rug and accessories source has plans for a 1.28 million-square-foot industrial facility in Bartow County, Ga. According to a report by the Rome (Ga.) News-Tribune, Southland Engineers ...
Tags: Furniture, Furnishing, mirrors, wall art
NanoH2O Inc is to supply nanocomposite reverse osmosis (RO) membranes for two desalination plants in Saudi Arabia. The first project, awarded by Al Fatah Water and Power International, is for phase II of the Jubail desalination plant. ...
Bend Research, part of Capsugel’s Dosage Form Solutions business unit, announced the addition of Capsugel’s Xcelodose precision powder-filling technology to its drug development process. This patented micro-dosing technology ...
Alzheon announced the launch of the company, the securing of initial private financing, and the signing of an exclusive license agreement to a novel clinical drug candidate for Alzheimer’s disease, a family of analogs, and a drug ...
Tags: Alzheon, Alzheimer's Disease
US-based clinical development firm AltheRx Pharmaceuticals has received a notice of allowance for its patent application from the US Patent and Trademark Office (USPTO) for the use of solabegron in combination with antimuscarinics at both ...
Cystic Fibrosis Foundation Therapeutics (CFFT), an affiliate of the CF Foundation, has provided $1.7m research award to US-based Savara Pharmaceuticals for advancing the development of AeroVanc (vancomycin hydrochloride inhalation powder). ...
Danish biotechnology firm Genmab has unveiled positive results from a Phase II study of its sclerosis drug candidate ofatumumab in relapsing-remitting multiple sclerosis (RRMS). In a randomized study of 232 patients with RRMS, treatment ...
Tags: Genmab, Sclerosis Drug
Allegro Ophthalmics has received approval from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to commence two Phase II clinical studies of integrin peptide therapy ALG-1001. The new trials, ...
Tags: Eye Disease Patients
US-based biotechnology firm GeoVax Labs has received a notice of allowance from the US Patent and Trademark Office (USPTO) for patent that covers compositions, methods and uses of the company's DNA/MVA vaccine in eliciting cellular and ...
Tags: Geovax Labs, HIV/Aids Vaccine
ISTO Technologies has completed enrollment of its Phase II clinical trial of NuQu, a novel, cell-based therapy for the treatment of pain and disability associated with degenerated spinal discs. The company has completed enrollment of 44 ...
Tags: ISTO Technologies, Back Pain Study
Daylight Solutions Inc of San Diego, CA, USA, which makes molecular detection and spectroscopic imaging systems based on mid-infrared quantum cascade lasers (QCLs) for scientific research, life science, industrial process control and ...
Tags: Daylight, Supplemental Funding